Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway.
- Published In:
- Scientific reports, 15(1), 13360 (2025)
- Authors:
- Fan, Bingge, Meng, Lingbing, Zheng, Xiao, Bai, Lei, Du, Yaping, Ding, Haiyan, Chen, Yu, Zhang, Yuna
- Database ID:
- RPEP-10887
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10887APA
Fan, Bingge; Meng, Lingbing; Zheng, Xiao; Bai, Lei; Du, Yaping; Ding, Haiyan; Chen, Yu; Zhang, Yuna. (2025). Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway.. Scientific reports, 15(1), 13360. https://doi.org/10.1038/s41598-025-97872-w
MLA
Fan, Bingge, et al. "Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway.." Scientific reports, 2025. https://doi.org/10.1038/s41598-025-97872-w
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide inhibits the proliferation of rat hepatic stella..." RPEP-10887. Retrieved from https://rethinkpeptides.com/research/fan-2025-liraglutide-inhibits-the-proliferation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.